Emma Palmer Foster, director of Discovery Park Ventures, shares her advice to early stage life sciences companies on how to improve their chances of gaining funding.
Key insights:
- Early stage life science companies often don't provide the evidence, and fail to provide research and clarity to their investors - leaving them without funding.
- Business ethic should be as strong as lab-know how - investors don’t just look at the science, they want to know whether companies can deliver on their promise.
- Learning from successful start-ups and approaching the pitch from an investor's perspective will facilitate these early stage companies into a fundable position.
The last decade has witnessed a boom in life science start-ups and that pace is set to continue as the search goes on to find improved treatments for diseases including Alzheimer’s and cancer.